TREMFYA® (guselkumab)
One-Press Patient-Controlled Injector

TREMFYA is approved for the treatment of adults with:

• Moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
• Active psoriatic arthritis.
• Moderately to severely active ulcerative colitis.
• Moderately to severely active Crohn’s disease.

This information is in supplement to the medication guide and instructions for Use. Prior to injection, patients should be trained by their healthcare provider.